SCHEMBL30937531

SCHEMBL30937531

COC(=O)CN1Cc2cc(F)ccc2NC1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PER2 O15055 2/20 0.43
▸ PDE4A P27815 1/20 0.41
▸ PDE4B Q07343 1/20 0.41
▸ PDE4C Q08493 1/20 0.41
▸ PDE4D Q08499 1/20 0.41
▸ MAPK1 P28482 2/20 0.39
▸ TRPV1 Q8NER1 1/20 0.39
▸ CASP3 P42574 1/20 0.39
▸ THRB P10828 1/20 0.39
▸ BRD4 O60885 3/20 0.39
▸ GAA P10253 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ CDK5 Q00535 1/20 0.38
▸ CDK5R1 Q15078 1/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ RAB9A P51151 2/20 0.37
▸ ALDH1A1 P00352 2/20 0.37
▸ MAPT P10636 2/20 0.37
▸ HSD17B10 Q99714 2/20 0.37
▸ KDM4E B2RXH2 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30937596 0.86 PER2 (0.45) PER2PDE4APDE4BPDE4CPDE4D
SCHEMBL30937538 0.84 PER2 (0.45) PER2PDE4APDE4BPDE4CPDE4D
SCHEMBL30937764 0.81 BRD4 (0.50) PER2BRD4GAAKMT2AMEN1
SCHEMBL3307027 0.81 BRD4 (0.50) PER2BRD4GAAKMT2AMEN1
SCHEMBL30937691 0.77 ACE (0.43) GAAKMT2AMEN1RAB9AALDH1A1
SCHEMBL30937645 0.76 GPR139 (0.47) PER2MAPK1THRB
SCHEMBL30937712 0.76 ACE (0.43) CASP3BRD4GAAKMT2AMEN1
SCHEMBL29546687 0.75 CTSG (0.45) BRD4GAACDK5CDK5R1ALDH1A1
SCHEMBL30937744 0.74 ACE (0.52) GAAKMT2ACDK5CDK5R1MEN1
SCHEMBL29546562 0.72 MAPK1 (0.55) PER2MAPK1CDK5CDK5R1DPP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4594307-A1 1,4-DIHYDROQUINAZOLINONE COMPOUNDS AND USES THEREOF EDGEWISE THERAPEUTICS, INC. (US) 2025-08-06 — — EP disclosed
WO-2024073426-A1 1,4-DIHYDROQUINAZOLINONE COMPOUNDS AND USES THEREOF EDGEWISE THERAPEUTICS, INC. (US) 2024-04-04 — — WO disclosed
Send feedback